博安生物(06955)股东将股票由中国证券登记结算香港转入中信证券经纪香港 转仓市值3.46亿港元

Group 1 - The core point of the article highlights that on January 26, shareholders of BGI Genomics (06955) transferred shares from China Securities Depository and Clearing Corporation Hong Kong to CITIC Securities Brokerage Hong Kong, with a market value of HKD 346 million, accounting for 6.32% of the total shares [1] - BGI Genomics announced that its board has been informed by its controlling shareholder, Green Leaf Pharmaceutical Group, regarding a proposed transfer of 11.9866 million H-shares by its wholly-owned subsidiary, Shandong Green Leaf Pharmaceutical Co., Ltd., to be executed on January 27, 2026, in accordance with the terms of the subscription agreement related to the exchangeable preferred shares [1]